Related Experiment Video
Updated: Jun 29, 2025

Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System
Published on: December 10, 2021
Huntington's disease: A clinical primer for acute and general physicians
Thomas H Massey1, Duncan J McLauchlan2
1University Hospital of Wales, Cardiff & Vale University Health Board, Cardiff, UK; Centre for Neuropsychiatric Genetics and Genomics, School of Medicine, Cardiff University, Hadyn Ellis Building, Maindy Road, Cardiff, UK; UK Dementia Research Institute at Cardiff University, Cardiff, UK.
Huntington's disease (HD) is a progressive neurodegenerative disorder affecting movement, mental health, and cognition. This review covers common presentations, therapeutic options, and advanced care considerations for HD patients.
Area of Science:
- Neuroscience
- Genetics
- Neurology
Background:
- Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder.
- It typically manifests in adulthood, causing progressive decline in motor function, cognition, and mental health.
- Current treatments focus on symptom management, as no disease-modifying therapies exist.
Purpose of the Study:
- To review common acute and chronic presentations in Huntington's disease patients.
- To discuss available therapeutic options for symptom relief.
- To outline specific considerations for managing advanced stages of HD.
Main Methods:
- Literature review of common presentations in Huntington's disease.
- Analysis of current therapeutic strategies for symptom management.
- Discussion of advanced care planning and considerations.
Main Results:
- Acute deteriorations in HD patients often signal underlying issues like infections or constipation.
- Management involves multidisciplinary support and medical treatments for distressing symptoms.
- Advanced HD requires specific care considerations, including palliative approaches.
Conclusions:
- Effective management of Huntington's disease relies on recognizing and addressing both chronic progression and acute complications.
- A comprehensive, multidisciplinary approach is crucial for optimizing patient care throughout the disease trajectory.
- Further research into disease-modifying treatments remains a critical unmet need.
Related Concept Videos
Parkinson's Disease: Overview
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Disorders of the Nervous Tissue
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...

